Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

7.4K
GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
7.4K
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

2.7K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

7.0K
The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
7.0K
Regulation of Heart Rates01:31

Regulation of Heart Rates

6.4K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
6.4K
Master Transcription Regulators02:23

Master Transcription Regulators

8.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.1K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

939
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
939

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision modification of heart failure signaling by CRISPR-Cas9 base editing.

Journal of molecular and cellular cardiology·2026
Same author

A human cardiomyocyte screen identifies optimized lipid nanoparticles for in vivo cardiac gene editing.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Nrf1 coordinates proteasome activity and autophagy to maintain cardiac proteostasis.

Communications biology·2026
Same author

Ablation of PKCα Phosphorylation by CRISPR-Cas9 Base Editing Rescues Heart Failure.

Circulation research·2026
Same author

Modulation of the JAK2-STAT3 pathway promotes expansion and maturation of human iPSC-derived myogenic progenitor cells.

Stem cell reports·2025
Same author

Precise gene editing of pathogenic Lamin A mutations corrects cardiac disease.

Proceedings of the National Academy of Sciences of the United States of America·2025

Related Experiment Video

Updated: Apr 19, 2026

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

9.2K

MyoR modulates cardiac conduction by repressing Gata4.

John P Harris1, Minoti Bhakta1, Svetlana Bezprozvannaya2

  • 1Department of Internal Medicine (Cardiology Division), UT Southwestern Medical Center, Dallas, Texas, USA.

Molecular and Cellular Biology
|December 10, 2014
PubMed
Summary
This summary is machine-generated.

MyoR, a novel transcription factor, regulates cardiac atrioventricular delay by inhibiting Cx30.2 expression. Its deletion in mice prolonged this delay, impacting cardiac rhythm.

More Related Videos

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.8K
Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

8.2K

Related Experiment Videos

Last Updated: Apr 19, 2026

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

9.2K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.8K
Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

8.2K

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Transcriptional Regulation

Background:

  • The cardiac conduction system, including the atrioventricular node (AVN), is crucial for coordinated electrical activation and optimized cardiac performance.
  • While AVN formation is increasingly understood, the transcriptional mechanisms governing AV delay in the mature AVN remain largely unknown.
  • Understanding AV delay regulation is vital for addressing cardiac rhythm variability.

Purpose of the Study:

  • To identify novel transcriptional regulators involved in controlling the delay of electrical impulse propagation at the atrioventricular node (AVN).
  • To elucidate the molecular mechanisms by which MyoR influences AVN gene expression and function.
  • To investigate the physiological consequences of MyoR dysregulation on cardiac conduction.

Main Methods:

  • Identification and characterization of MyoR as a novel transcription factor in Cx30.2(+) cells of the AVN.
  • Analysis of MyoR's interaction with the Cx30.2 enhancer and its effect on AVN-specific gene expression.
  • Biochemical assays to determine MyoR's repression domains and interaction with Gata4.
  • In vivo studies using MyoR-deficient mice to assess the impact on Cx30.2 expression and AV delay.

Main Results:

  • MyoR was identified as a transcription factor specifically expressed in the AVN.
  • MyoR directly inhibits a Cx30.2 enhancer, thereby regulating AVN-specific gene expression.
  • MyoR interacts with Gata4 to mediate transcriptional repression through distinct N-terminal and C-terminal domains.
  • Genetic deletion of MyoR in mice led to a 50% increase in Cx30.2 expression and a 13% prolongation of AV delay.

Conclusions:

  • MyoR plays a critical role in modulating a Gata4-dependent regulatory circuit essential for establishing proper AV delay.
  • These findings reveal a novel mechanism for controlling cardiac electrical conduction timing.
  • The study suggests that MyoR's function in AV delay may have broader implications for understanding cardiac rhythm variability in the general population.